Beyond glycemic control—the primary goal of insulin therapy—two important challenges in the management of T1DM are weight gain and the paradoxical increase in glucagon levels, which is often refractory to exogenous insulin administration [53]. The gene discussed is GCG; the disease is type 1 diabetes mellitus.